Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06684366

Chronic Coronary Syndrome Real Practice and Guidelines

Chronic Coronary Syndrome...real Practice and Guidelines...A Single Center Registery

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluate Adherence to the 2019 ESC Guidelines and standard care protocols for managing patients with the chronic coronary syndrome within the center

Detailed description

Coronary artery disease (CAD) refers to the presence of atherosclerotic plaques in the coronary arteries, Which can be non-obstructive or obstructive. It represents a major cause of morbidity, mortality, Hospitalization and health expenditure. The most recent European Guidelines for the diagnosis and management of CCS delineate six common CCS scenarios: patients with suspected CAD and stable angina symptoms and/or dyspnea; patients with new onset of heart failure or left ventricular dysfunction and suspected CAD; asymptomatic and symptomatic patients with stabilized symptoms within one year after an acute coronary syndrome, or patients with recent revascularisation; asymptomatic and symptomatic patients beyond one year after initial diagnosis or revascularisation; Patients with angina and suspected vasospastic or microvascular disease; Asymptomatic subjects in whom CAD is detected at screening. Although these scenarios are heterogeneous, they are associated with an increased risk of acute events, and the stability of CCS patients over time depends on prompt diagnosis, optimal treatment and secondary prevention strategies, including Lifestyle modifications, and pharmacotherapy.

Conditions

Interventions

TypeNameDescription
DRUGStatins (atorvastatin or simvastatin)A resting transthoracic echocardiogram Non-invasive functional imaging for myocardial ischemia or coronary computed tomography angiography (CCTA) is recommended as the initial test for diagnosing CAD in symptomatic patients in whom obstructive CAD cannot be excluded by clinical assessment alone

Timeline

Start date
2024-10-22
Primary completion
2025-10-22
Completion
2025-10-22
First posted
2024-11-12
Last updated
2024-11-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06684366. Inclusion in this directory is not an endorsement.